Expertises
Medicine & Life Sciences
# Biomedical Technology Assessment
# Breast Neoplasms
# Budgets
# Cost-Benefit Analysis
# Costs And Cost Analysis
# Ipilimumab
# Melanoma
# Tumor-Infiltrating Lymphocytes
Publicaties
Recent
Patel, S.
, Lindenberg, M., Rovers, M. M.
, Harten, W. H. V.
, Ruers, T. J. M., Poot, L.
, Retel, V. P., & Grutters, J. P. C. (2022).
Understanding the Costs of Surgery: A Bottom-Up Cost Analysis of Both a Hybrid Operating Room and Conventional Operating Room.
International Journal of Health Policy and Management,
11(3), 299-307.
https://doi.org/10.34172/ijhpm.2020.119
Lindenberg, M. A.
, Retel, V. P., Kieffer, J. M., Wijburg, C., Fossion, L., van der Poel, H.
, & van Harten, W. H. (2021).
Long-term functional outcomes after robot-assisted prostatectomy compared to laparoscopic prostatectomy: Results from a national retrospective cluster study.
European journal of surgical oncology,
47(10), 2658-2666.
https://doi.org/10.1016/j.ejso.2021.06.006
Lindenberg, M.
, Retèl, V.
, van Til, J., Kuhlmann, K.
, Ruers, T.
, & van Harten, W. (2021).
Selecting Image-Guided Surgical Technologies in Oncology: A Surgeon's Perspective.
Journal of Surgical Research,
257, 333-343.
https://doi.org/10.1016/j.jss.2020.08.003
Lindenberg, M.
, Retèl, V., Rohaan, M., Van Den Berg, J., Haanen, J.
, & Van Harten, W. (2020).
Evaluating different adoption scenarios for TIL-therapy and the influence on its (early) cost-effectiveness.
BMC cancer,
20(1), [712].
https://doi.org/10.1186/s12885-020-07166-9
Lindenberg, M., van Beek, A.
, Retèl, V., van Duijnhoven, F.
, & van Harten, W. (2020).
Early budget impact analysis on magnetic seed localization for non-palpable breast cancer surgery.
PLoS ONE,
15(5), [e0232690].
https://doi.org/10.1371/journal.pone.0232690
Lindenberg, M. A.
, Retl, V. P., van den Berg, J. H., Geukes Foppen, M. H., Haanen, J. B.
, & Van Harten, W. H. (2018).
Treatment with Tumor-infiltrating Lymphocytes in Advanced Melanoma Evaluation of Early Clinical Implementation of an Advanced Therapy Medicinal Product.
Journal of Immunotherapy,
41(9), 413-425.
https://doi.org/10.1097/CJI.0000000000000245
Retel, V. P.
, Steuten, L. M. G., Foppen, M. H. G.
, Mewes, J. C.
, Lindenberg, M. A., Haanen, J. B. A. G.
, & van Harten, W. H. (2018).
Early cost-effectiveness of tumor infiltrating lymphocytes (TIL) for second line treatment in advanced melanoma: A model-based economic evaluation.
BMC cancer,
18(1), [895].
https://doi.org/10.1186/s12885-018-4788-5
Lindenberg, M. A.
, Retèl, V. P., Foppen, M. H. G., van den Berg, J., Haanen, J.
, & van Harten, W. H. (2017).
Evaluation of early implementation of tumor-infiltrating lymphocytes in treating advanced melanoma in an academic setting: a constructive technology analysis.
European journal of cancer,
72(S1), S130-S131. [1263].
https://doi.org/10.1016/S0959-8049(17)30506-3
Lindenberg, M. M. A.
, Miquel Cases, A.
, Retèl, V. P., Sonke, G. S., Wesseling, J., Stokkel, M. P. M.
, & van Harten, W. H. (2017).
Imaging performance in guiding response to neoadjuvant therapy according to breast cancer subtypes: A systematic literature review.
Critical Reviews in Oncology/Hematology,
112, 198-207.
https://doi.org/10.1016/j.critrevonc.2017.02.014
Pure Link
Contactgegevens
Bezoekadres
Universiteit Twente
Drienerlolaan 5
7522 NB Enschede
Postadres
Universiteit Twente
Postbus 217
7500 AE Enschede